hMAGE-A1 overexpression reduces TNF-α cytotoxicity in ME-180 cells

Molecules and Cells

Volumn 14, Issue 1, 2002, Pages 122-129

  Park, Joo Hung ^a   Kong, Gee Hye ^a   Lee, Soo Woong ^a  

^a Changwon National University   (South Korea)

Author keywords

Cytotoxicity; MAGE; TNF

Indexed keywords

MELANOMA ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 3; PROTEIN MELANOMA ANTIGEN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; TUMOR PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM;

ANTINEOPLASTIC AGENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037206266     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ashkenazi, A. and Dixit, V. M. (1998) Death receptors: signaling and modulation. Science 281, 1305-1308.
2. Baeuerle, P. and Baltimore, D. (1996) NF-kappaB: ten years after. Cell 87, 13-20.
3. Becker, J. C., Gillitzer, R., and Brocker, E.-B. (1994) A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int. J. Cancer 58, 346-348.
4. Beg, A. A. and Baltimore, D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784.
5. Boccaccio, I., Glatt-Deelev, H., Watrin, F., Roeckell, N., Laland, M., and Muscatelli, F. (1999) The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Hum. Mol. Genet. 8, 2497-2505.
6. Chomez, P., De Backer, O., Bertrand, M., De Plaen, E., Boon, T., and Lucas, S. (2001) An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 61, 5544-5551.
7. Dabovic, B., Zanaria, E., Bardoni, B., Lisa, A., Bordignon, C., Russo, V., Matessi, C., Traversari, C., and Camerino, G. (1995) A family of rapidly evolving genes from the sex reversal critical region in Xp21. Mamm. Genome 6, 571-580.
8. Darnay, B. G. and Aggarwal, B. B. (1997) Early events in TNF signaling: a story of associations and dissociations. J. Leukocyte Biol. 61, 559-566.
9. De Backer, O., Verheyden, A.-M., Martin, B., Godelaine, D., De Olaen, E., Brasseur, R., Avner, P., and Boon, T. (1995) Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes, Genomics 28, 74-83.
10. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J.-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethe, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40, 360-369.
11. De Plaen, E., De Backer, O., Arnaud, D., Bonjean, B., Chomez, P., Martelange, V., Avner, P., Baldacci, P., Babinet, C., Hwang, S.-Y., Knowles, B., and Boon, T. (1999) A new family of mouse genes homologous to the human MAGE genes. Genomics 55, 176-184.
12. De Smet, C., Lurquin, C., van der Bruggen, P., De Plaen, E., Brasseur, F., and Boon, T. (1994) Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 39, 121-129.
13. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921-930.
14. Gillespie, A. M., Rodgers, S., Wilson, A. P., Tidy, J., Rees, R. C., Coleman, R. E., and Murray, A. K. (1998) MAGE, BAGE and GAGE: tumor antigen expression in benign and malignant ovarian tissue. Br. J. Cancer 78, 816-821.
15. Hayashi, Y., Matsuyama, K., Takagi, K., Sugiura, H., and Yoshikawa, K. (1995) Arrest of cell growth by necdin, a nuclear protein expressed in postmitotic neurons. Biochem. Biophys. Res. Commun. 213, 317-324.
16. Hoon, D. S. B., Yuzuki, D., Hayashida, M., and Morton, D. L. (1995) Melanoma patients immunized with cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J. Immunol. 154, 730-737.
17. Houghton, A. N. (1994) Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180, 1-4.
18. Hsu, H., Shu, H.-B., Pan, M.-G., and Goeddel, D. V. (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
19. Ishii, H. H., Etheridge, M. R., and Gobe, G. C. (1995) Cycloheximide-induced apoptosis in Burkitt lymphoma (BJA-B) cells with and without Epstein-Barr virus infection. Immmunol. Cell Biol. 73, 463-468.
20. Jungbluth, A. A., Busam, K. J., Kolb, D., Iversen, K., Coplan, K., Chen, Y.-T., Spagnoli, G. C., and Old, L. J. (2000) Expression of MAGE-antigens in normal tissues and cancer. Int. J. Cancer 85, 460-465.
21. Karin, M., Liu, Z., and Zandi, E. (1997) AP-1 function and regulation. Curr. Opin. Cell. Biol. 9, 240-246.
22. Kocher, T., Schultz-Thater, E., Gudat, F., Schaefer, C., Casorati, G., Juretic, A., Willimann, T., Harder, F., Heberer, M., and Spagnoli, G. C. (1995) Identification and intracellular location of MAGE-3 gene product. Cancer Res. 55, 2236-2239.
23. Lee, J.-H. (2001) Production of tumor associated antigen MAGE protein, development and function of monoclonal antibody. M.S. Thesis, Changwon National University, Changwon, Korea.
24. Lee, J.-H., Sung, B.-H., Youn, H.-J., and Park, J.-H. (2000) Identification, expression, and nuclear location of murine Mage-b2 protein, a tumor-associated antigen. Mol. Cells 10, 647-653.
25. Liu, Z.-G., Hsu, H., Goeddel, D., and Karin, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87, 565-576.
26. Lucas, S., De Smet, C., Arden, K. C., Viars, C. S., Lethe, B., Lurquin, C., and Boon, T. (1998) Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res. 58, 743-752.
27. Lucas, S., Brasseur, F., and Boon, T. (1999) A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells. Cancer Res. 59, 4100-4103.
28. Lurquin, C., De Smet, C., Brasseur, F., Muscatelli, F., Martelange, V., De Plaen, E., Brasseur, R., Monaco, A. P., and Boon, T. (1997) Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46, 397-408.
29. Malinin, N. L., Boldin, M. K., Kovalenko, A. V., and Wallach, D. (1997) MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540-544
30. Maruyama, K., Usami, M., Aizawa, T., and Yoshikawa, K. (1991) A novel brain-specific mRNA encoding nuclear protein (necdin) expressed in neurally differentiated embryomal carcinoma cells. Biochem. Biophys. Res. Commun. 178, 291-296.
31. Masuda, Y., Sasaki, A., Shibuya, H., Ueno, N., Ikeda, K., and Watanabe, K. (2001) Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function. J. Biol. Chem. 276, 5331-5338.
32. Muscatelli, F., Walker, A. P., De Plaen, E., Stafford, A. N., and Monaco, A. P. (1995) Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc. Natl. Acad. Sci. USA 92, 4987-4991.
33. Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355-365.
34. Neale, M. L., Fiera, A., and Matthews, N. (1988) Involvement of phospholipase A2 activation in tumor cell killing by tumor necrosis factor. Immunology 64, 81-85.
35. Osterlund, C., Tobonen, V., Forslund, O. K., and Nordqvist, K. (2000) Mage-b4, a novel melanoma antigen (MAGE) gene specifically expressed during germ cell differentiation. Cancer Res. 60, 1054-1061.
36. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., and Donner, D. B. (1999) NF-kappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85.
37. Palombella, F. C. and Vilcek, J. (1989) Mitogenic and cytotoxic actions of tumor necrosis factor in Balb/c 3T3 cells. Role of phospholipase activation. J. Biol. Chem. 264, 18128-18136.
38. Park, J.-H. and Lee, S. W. (2002) Hypertonicity induction of MAGE, a tumor-associated antigen. Mol. Cells 13, 288-295.
39. Park, J.-H., Kim, C.-J., Lee, J.-H., Shin, S.-H., Chung, G.-H., and Jang, Y.-S. (1999) Effective immunotherapy of cancer by DNA vaccination. Mol. Cells 9, 384-391.
40. Pold, M., Zhou, J., Chen, G. L., Hall, J. M., Vescio, R. A., and Berenson, J. R. (1999) Identification of a new, unorthodox member of the MAGE gene family. Genomics 59, 161-167.
41. Reid, T. R., Torti, F. M., and Ringold, G. M. (1989) Evidence for two mechanisms by which tumor necrosis factor kills cells. J. Biol. Chem. 264, 4583-4589.
42. Saburi, S., Nadano, D., Akama, T. O., Hirama, K., Yamanouchi, K., Naito, K., Tojo, H., Tachi, C., and Fukuta, M. N. (2001) The trophinin gene encodes a novel group of MAGE proteins, magphinins, and regulates cell proliferation during gametogenesis in the mouse. J. Biol. Chem. 276, 49378-49389.
43. Salehi, A. H., Roux, P. P., Kubu, C. J., Zeindler, C., Bhakar, A., Tannis, L.-L., Verdi, J. M., and Barker, P. A. (2000) NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 27, 279-288.
44. Shichijo, S., Hayashi, A., Takamori, S., Tsunosue, R., Hoshino, T., Sakata, M., Kuramoto, T., Oizumi, K., and Itoh, K. (1995) Detection of MAGE-4 protein in lung cancers. Int. J. Cancer 64, 158-165.
45. Stone, B., Schummer, M., Paley, P. J., Crawford, M., Ford, M., Urban, N., and Nelson, B. H. (2001) MAGE-F1, a novel ubiquitously expressed member of the MAGE family. Gene 267, 173-182.
46. Suzuki, K., Tsujitani, S., Kinishi, I., Yamaguchi, Y., Hirooka, Y., and Kaibara, N. (1999) Expression of MAGE genes and survival in patients with hepatocellular carcinoma. Int. J. Oncol. 15, 1227-1232.
47. Taback, B., Chan, A. D., Kuo, C. T., Bostick, P. J., Wang, H. J., Giuliano, A. E., and Hoon, D. S. (2001) Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res. 61, 8845-8850.
48. Takahashi, K., Shichijo, S., Noguchi, M., Hirohata, M., and Itoh, K. (1995) Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 55, 3478-3482.
49. Taniura, H., Taniguchi, N., Hara, M., and Yoshikawa, K. (1998) Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J. Biol. Chem. 273, 720-728.
50. van den Eynde, B. J. and van der Bruggen, P. (1997) T cell defined tumor antigens. Curr. Opin. Immunol. 9, 684-693.
51. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., van den Eynde, B., Knuth, A., and Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.
52. Wong, G. H. W. and Goeddel, D. V. (1994) Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152, 1751-1755.